Skip to content

Paired pulse TMS-EEG in epilepsy: improving the evaluation of therapeutic efficacy

Paired pulse TMS-EEG in epilepsy: improving the evaluation of therapeutic efficacy - Paired pulse TMS-EEG in epilepsy - therapeutic efficacy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON47189
Enrollment
80
Registered
2014-08-19
Start date
2016-09-20
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

convulsion epilepsy

Interventions

All patients will undergo 3 to 4 paired pulse TMS sessions, over a period of one year. The first TMS session will take place while the patient is still drug naïve, the second session 8 to 12 weeks a

Sponsors

Universiteit Twente
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Drug naïve epilepsy patients starting with AEDs * Diagnosis of epilepsy, either generalized or focal * Drug naïve, no prior use of AEDs * Ability to understand and comply with the instructions for the TMS sessions

Exclusion criteria

Exclusion criteria: * Younger than 18 years * Contra-indications of TMS (although not absolute): (possibility of) pregnancy, metal objects in brain/skull, cochlear implant, deep brain stimulator, history of spinal cord surgery, drains in the spinal cord or ventricles, use of seizure threshold lowering medication * Follow-up impossible due to logistical reasons

Design outcomes

Primary

MeasureTime frame
Primary study parameters are the characteristics of the MEP (resting motor threshold (rMT) and long intracortical inhibition (LICI)) and TEP (amplitude and latency of peaks).

Secondary

MeasureTime frame
Secondary study parameters include additional signal analysis methods applied on the MEP and TEP. For example, wavelet analysis of early and late TEPs and the spatio-temporal characteristics of the TEP. Other study parameters which are documented include: age, gender, handedness, seizure history, type of epilepsy; generalized or focal, type and dose of AEDs, EEG abnormalities (if applicable) and MRI abnormalities (if applicable).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)